Clinical trial
Repositioning Omega-3 Fatty Acids For Treatment Of Glycaemia And Cardiometabolic Disease
NCT07677995 is registered in ClinicalTrials.gov with University of Ulster as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repositioning Omega-3 Fatty Acids For Treatment Of Glycaemia And Cardiometabolic Disease
- Lead sponsor
- University of Ulster
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- September 30, 2026
- Completion date
- February 28, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, omega-3 fatty acids, type 2 diabetes